Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. (Q51997752)
Jump to navigation
Jump to search
scientific article published in October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. |
scientific article published in October 2004 |
Statements
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. (English)
1 reference
James G Krueger
1 reference
Yulia Vugmeyster
1 reference
Toyoko Kikuchi
1 reference
Francesca Chamian
1 reference
Mark Kagen
1 reference
Patricia Gilleaudeau
1 reference
Edmund Lee
1 reference
Kathy Howell
1 reference
Sarah Bodary
1 reference
Wolfgang Dummer
1 reference
1 October 2004
1 reference
113
1 reference
1
1 reference
38-46
1 reference